Daniel J Bromberg1,2, Kenneth H Mayer3,4, Frederick L Altice2,5,6. 1. Department of Social and Behavioral Sciences, Yale University School of Public Health. 2. Yale Center for Interdisciplinary Research on AIDS, Yale University, New Haven, Connecticut. 3. The Fenway Institute, Fenway Health. 4. Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. 5. Section of Infectious Diseases, Department of Medicine, Yale University School of Medicine. 6. Department of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, Connecticut, USA.
Abstract
PURPOSE OF REVIEW: We will present recent articles focusing on HIV synergistic interactions with other sexually transmitted infections, tuberculosis, and hepatitis, as well as recent advances in the study of social and behavioral determinants that facilitate this clustering of infectious disease. For each synergistic interaction, we highlight evidence-based interventions that clinicians and policymakers should consider to tackle HIV and infectious disease syndemics. RECENT FINDINGS: Significant advances in understanding the behavioral and structural determinants of HIV and other infectious disease synergisms have been made in the past years. Intervention strategies based on these new models have also been developed. It is now well understood that treating infectious disease syndemics will require a multidisciplinary and multipronged approach. SUMMARY: HIV is synergistic with multiple other infectious diseases because the risk behaviors that lead to HIV acquisition may be similar to the other infections. The influence of HIV on the other infection may be due to immunosuppression associated with disease progression resulting in increased susceptibility (e.g., HIV and tuberculosis), especially when patients are not virologically suppressed using antiretroviral therapy. In reverse, another infectious disease may, when not treated, influence HIV disease progression. Social/structural determinants like homelessness, mass incarceration, and structural discrimination precipitate psychiatric comorbidity, substance use, and risky sex behavior which lead to the spread and co-occurrence of infectious disease.
PURPOSE OF REVIEW: We will present recent articles focusing on HIV synergistic interactions with other sexually transmitted infections, tuberculosis, and hepatitis, as well as recent advances in the study of social and behavioral determinants that facilitate this clustering of infectious disease. For each synergistic interaction, we highlight evidence-based interventions that clinicians and policymakers should consider to tackle HIV and infectious disease syndemics. RECENT FINDINGS: Significant advances in understanding the behavioral and structural determinants of HIV and other infectious disease synergisms have been made in the past years. Intervention strategies based on these new models have also been developed. It is now well understood that treating infectious disease syndemics will require a multidisciplinary and multipronged approach. SUMMARY: HIV is synergistic with multiple other infectious diseases because the risk behaviors that lead to HIV acquisition may be similar to the other infections. The influence of HIV on the other infection may be due to immunosuppression associated with disease progression resulting in increased susceptibility (e.g., HIV and tuberculosis), especially when patients are not virologically suppressed using antiretroviral therapy. In reverse, another infectious disease may, when not treated, influence HIV disease progression. Social/structural determinants like homelessness, mass incarceration, and structural discrimination precipitate psychiatric comorbidity, substance use, and risky sex behavior which lead to the spread and co-occurrence of infectious disease.
Authors: Gregorio A Millett; John L Peterson; Stephen A Flores; Trevor A Hart; William L Jeffries; Patrick A Wilson; Sean B Rourke; Charles M Heilig; Jonathan Elford; Kevin A Fenton; Robert S Remis Journal: Lancet Date: 2012-07-20 Impact factor: 79.321
Authors: W C Levine; V Pope; A Bhoomkar; P Tambe; J S Lewis; A A Zaidi; C E Farshy; S Mitchell; D F Talkington Journal: J Infect Dis Date: 1998-01 Impact factor: 5.226
Authors: Gabriel J Culbert; Agung Waluyo; Mariska Iriyanti; Azalia P Muchransyah; Adeeba Kamarulzaman; Frederick L Altice Journal: Drug Alcohol Depend Date: 2015-01-25 Impact factor: 4.492
Authors: Kate Buchacz; Pragna Patel; Melanie Taylor; Peter R Kerndt; Robert H Byers; Scott D Holmberg; Jeffrey D Klausner Journal: AIDS Date: 2004-10-21 Impact factor: 4.177
Authors: Daniel J Bromberg; Mary M Tate; Arash Alaei; Julia Rozanova; Saifuddin Karimov; Dilshod Saidi; Kamiar Alaei; Frederick L Altice Journal: AIDS Behav Date: 2021-06-30
Authors: Savita Pahwa; Steven Deeks; Shimian Zou; Natalie Tomitch; Leia Miller-Novak; Elisabet Caler; Amy Justice; Ned Sacktor; Dana Gabuzda; Peter W Hunt; Todd Brown; Ann Kurth; Stefan Baral; Michael Mugavero; Kenneth H Mayer; Emily Mendenhall; Roger Detels; Vincent Mutabazi Journal: J Acquir Immune Defic Syndr Date: 2021-01-01 Impact factor: 3.771
Authors: Anthony J Eller; Elizabeth E DiDomizio; Lynn M Madden; Jennifer D Oliva; Frederick L Altice; Kimberly A Johnson Journal: Ann Med Date: 2022-07-01 Impact factor: 5.348
Authors: Jeffrey V Lazarus; Kelly Safreed-Harmon; Adeeba Kamarulzaman; Jane Anderson; Ricardo Baptista Leite; Georg Behrens; Linda-Gail Bekker; Sanjay Bhagani; Darren Brown; Graham Brown; Susan Buchbinder; Carlos Caceres; Pedro E Cahn; Patrizia Carrieri; Georgina Caswell; Graham S Cooke; Antonella d'Arminio Monforte; Nikos Dedes; Julia Del Amo; Richard Elliott; Wafaa M El-Sadr; María José Fuster-Ruiz de Apodaca; Giovanni Guaraldi; Tim Hallett; Richard Harding; Margaret Hellard; Shabbar Jaffar; Meaghan Kall; Marina Klein; Sharon R Lewin; Ken Mayer; Jose A Pérez-Molina; Doreen Moraa; Denise Naniche; Denis Nash; Teymur Noori; Anton Pozniak; Reena Rajasuriar; Peter Reiss; Nesrine Rizk; Jürgen Rockstroh; Diana Romero; Caroline Sabin; David Serwadda; Laura Waters Journal: Nat Commun Date: 2021-07-16 Impact factor: 14.919